logo
logo

Prime Therapeutics Closes $1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy And Medical Drug Management Expertise

Prime Therapeutics Closes $1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy And Medical Drug Management Expertise

12/05/22, 1:14 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgeagan
Industry
insurance
Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) today finalized the previously announced acquisition of Magellan Rx Management, (Magellan Rx), the pharmacy division of Magellan Health, from Centene Corporation. The agreement unites Prime's strong foundation of pharmacy benefit management (PBM) capabilities with Magellan Rx's industry-leading total specialty drug management expertise to create a diversified pharmacy solutions organization serving commercial markets and government programs.

Company Info

Company
Prime Therapeutics
Location
Eagan, Minnesota, United States
Company info
Everything we do is connected to helping people get the medicine they need to feel better and live well. It’s meaningful work and we’ve been doing it for over 24 years. In the pharmacy benefit management (PBM) industry, we’re different. We’re owned by 18 not-for-profit Blue Cross and Blue Shield health plans. This allows us to control costs and empower our employees to put members first. It’s a successful combination. We have the lowest pharmacy trend in the industry and serve 28+ million members throughout the US.

Related People

Upgrade to Unlock

Unlock Verified Contacts + AI Outreach

Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.

Kh

KhExecutive

Email hidden • Upgrade to unlock

Upgrade & Unlock

Trusted by teams at Google, Oracle, HubSpot & more